Tesovnik Tine, Kovač Jernej, Pohar Katka, Hudoklin Samo, Dovč Klemen, Bratina Nataša, Trebušak Podkrajšek Katarina, Debeljak Maruša, Veranič Peter, Bosi Emanuele, Piemonti Lorenzo, Ihan Alojz, Battelino Tadej
Department of Pediatric Endocrinology, Diabetes and Metabolic Diseases, University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Clinical Institute of Special Laboratory Diagnostics, University Medical Centre Ljubljana, University Children's Hospital, Ljubljana, Slovenia.
Front Cell Dev Biol. 2020 Mar 31;8:202. doi: 10.3389/fcell.2020.00202. eCollection 2020.
Extracellular vesicles with their molecular cargo can modulate target cell response and may affect the pathogenesis of diseases. The extracellular vesicles containing micro-RNAs (miRNAs), which are often studied as disease biomarkers, but rarely as mediators of the disease development. The role of extracellular vesicles derived miRNAs in type 1 diabetes is currently not well established. We observed a fraction of blood plasma extracellular vesicles positive for membrane proteins potentially associated with insulin-producing beta-cells and identified differentially expressed extracellular vesicles derived miRNAs in individuals with type 1 diabetes. These differentially expressed extracellular vesicles derived human miRNAs in participants with type 1 diabetes and participants with Langerhans islets beta-cells destruction showed the ability to activate TLR7/8 signaling cascade and increase activation as well as cytotoxicity of the effector blood immune cells with cytokine and chemokine release. Our results illustrate extracellular vesicles derived human miRNAs as modulators of the immune system in type 1 diabetes autoimmunity, providing potentially new insight into the pathogenesis of the disease, and novel molecular targets for intervention and type 1 diabetes prevention.
携带其分子货物的细胞外囊泡可以调节靶细胞反应,并可能影响疾病的发病机制。含有微小RNA(miRNA)的细胞外囊泡,人们经常将其作为疾病生物标志物进行研究,但很少将其作为疾病发展的介质。目前,细胞外囊泡衍生的miRNA在1型糖尿病中的作用尚未明确。我们观察到一部分血浆细胞外囊泡对可能与产生胰岛素的β细胞相关的膜蛋白呈阳性,并鉴定出1型糖尿病患者中差异表达的细胞外囊泡衍生的miRNA。这些在1型糖尿病患者和朗格汉斯胰岛β细胞破坏患者中差异表达的细胞外囊泡衍生的人类miRNA显示出激活TLR7/8信号级联反应的能力,并通过细胞因子和趋化因子的释放增加效应血液免疫细胞的激活以及细胞毒性。我们的结果表明,细胞外囊泡衍生的人类miRNA是1型糖尿病自身免疫中免疫系统的调节剂,为该疾病的发病机制提供了潜在的新见解,并为干预和预防1型糖尿病提供了新的分子靶点。